Skip to main content
. Author manuscript; available in PMC: 2019 Oct 15.
Published in final edited form as: Biol Psychiatry. 2018 Feb 15;84(8):582–590. doi: 10.1016/j.biopsych.2018.01.027

Figure 1.

Figure 1

Summary of the study’s double-blind, placebo-controlled, crossover design showing the medication taper and drug-free period in relation to the imaging scans (green circles), infusions (red triangles), and rating scales (blue rectangles) in both the placebo and ketamine study arms.